Sponsor or institution

Clinical trials and research at National Institutes of Health Clinical Center (CC)

• 630Clinical trials
• 2New in 30 days
• 22Countries

Newest trials

All recruiting trials (newest 150 of 630)

• VLCPUFA-rich fish oil and standard DHA oil: who reaches a higher omega-3 index?

  This study tests whether VLCPUFA-rich fish oil raises the blood omega-3 index more than a standard DHA-rich fish oil in healthy adults aged 18–60.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07882160

• Blood biomarkers for immune-related neuropsychiatric conditions

  This study tests whether blood biomarkers can help identify neuropsychiatric disorders that may be linked to the immune system in people of any age.

  Recruiting at 3 sites National Institutes of Health Clinical Center (CC) · Los Angeles, California and 2 other locations · NCT07877246

• First-in-human imaging of PDE4D with [11C]JMJ-129-d2 in healthy volunteers

  A new PET tracer called [11C]JMJ-129-d2 is being tested in healthy adults to see if it safely and reliably images the brain’s PDE4D enzyme and to measure how the tracer distributes in the body.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07853781

• Pain patterns in rheumatic diseases: see if pain works differently in patients and healthy people

  This observational study tests how pain is experienced and measured in people with rheumatic diseases compared with healthy volunteers.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07829497

• Augmenting Parent Management Training with a Smartphone Tool

  This study tests whether adding a smartphone app to parent management training helps reduce irritability and temper outbursts in kids aged 8–13 with disruptive behavior disorders.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07764536

• How healthy adults look at faces and other images with their eyes

  This study tests how healthy adults direct their gaze and pay attention to visual images, including faces, to see how basic visual features influence eye movements.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07756853

• Prisoners' views on who should decide medical care if they cannot

  This survey asks people in prison who they would want to make medical decisions for them if they become unable to decide for themselves.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07751731

• Can cognitive training plus psilocybin boost brain health in older adults and early Alzheimer's

  This trial tests whether taking psilocybin twice, alongside a four-week cognitive training program, can improve brain function in adults 65+ with mild cognitive impairment or early Alzheimer’s and in healthy older adults.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Baltimore, Maryland · NCT07721467

• Dengue virus challenge in healthy adults to study immune responses

  Researchers will infect healthy adults with a weakened dengue virus to see how their bodies respond and how past exposure affects the reaction.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07706686

• Test of a new PET tracer to detect fungal infections in adults

  Researchers are testing a new PET tracer, 18F-Fluorocellobiose, to see if it helps find fungal infections in adults, including healthy volunteers and patients with invasive mold infections.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07704333

• Brain imaging with a new tracer to map alpha-1A receptors in healthy adults

  A new PET tracer called 11C-ARMI will be tested in healthy adults to see how it highlights alpha-1A adrenoreceptors in the brain and body.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07686393

• IL-15 superagonist with or without a PSA vaccine in biochemically recurrent prostate cancer after SBRT

  This study tests whether the drug N-803, alone or with a PSA-targeted vaccine, can lower PSA in men with biochemically recurrent prostate cancer after prior SBRT.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07686380

• Trisomy 8 Mosaicism Health Journey: What We’re Learning Over Time

  This study tests how trisomy 8 mosaicism and related autoinflammatory conditions unfold over many years by following affected individuals and their healthy relatives.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07683104

• IL-12–producing immune cells for relapsed or refractory solid tumors

  This study tests whether immune cells engineered to secrete IL-12 (IL-12 GEMys) can help the body fight relapsed or treatment‑refractory solid tumors.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07672483

• Docetaxel and SX-682 in head and neck cancers and prostate cancer

  This trial tests a new drug SX-682 together with docetaxel in adults whose head and neck cancers or prostate cancer have returned or spread.

  Recruiting Phase 1/2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07667400

• Ketoconazole's effect on the daily cortisol rhythm in MACS

  The study tests whether a single 400 mg dose of ketoconazole can modify the daily cortisol rhythm in adults with Mild Autonomous Cortisol Secretion (MACS) compared with healthy volunteers.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07649317

• PH Biorepository for Translational Research

  This project collects blood samples and health information from adults with or suspected to have pulmonary hypertension to build a biorepository for future biomarker research.

  Recruiting National Institutes of Health Clinical Center (CC) · Baltimore, Maryland and 2 other locations · NCT07647549

• Therapy approaches for irritability in youths: active treatments vs nonactive psychoeducation

  This study tests whether active psychotherapies for irritability in kids aged 8–16.5 years work better than nonactive, time-matched psychoeducation for children and their parents.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07640802

• Olfactory function and decision-making in people with HIV and/or substance use

  This study tests how the sense of smell relates to decision-making in adults with HIV, substance use, both, or neither.

  Recruiting National Institutes of Health Clinical Center (CC) · Baltimore, Maryland · NCT07637669

• Measuring PDE4B in the brain and body with a new PET tracer in healthy adults

  This study tests a new PET tracer, [11C]ZTP-1, to see if it can measure PDE4B levels in healthy adults.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07625345

• Longitudinal Immunophenotyping of People with Inflammatory Bowel Disease

  This study will follow adults with Crohn's disease or ulcerative colitis (and some healthy relatives) over three years to see how their immune cells change over time and how genetics and diet relate to their disease.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07619547

• CSF sample collection from people with metastatic breast cancer to see brain metastasis risk

  This study tests whether spinal fluid and other samples can help predict brain metastases in adults with metastatic HER2-positive or triple-negative breast cancer who have not yet shown brain involvement.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07619534

• See if 18F-FAPI-74 PET/CT can better detect fibrosis in heart and lung disease

  Researchers are testing a new PET/CT tracer, 18F-FAPI-74, to see if it can reveal early fibrotic changes in people with heart and lung diseases who are at risk for tissue scarring.

  Recruiting Phase 3 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07613099

• Partial stem cell transplant for sickle cell disease and beta-thalassemia using matched donors

  This study tests a partial stem cell transplant from matched donors to help people with severe sickle cell disease or beta-thalassemia see if more donor cells can persist long-term.

  Recruiting Phase 1/2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07599176

• TriAdeno and N-803 vaccine in early prostate cancer on active surveillance

  A vaccine combo called TriAdeno plus the N-803 drug is being tested to see if it can help slow or stop growth in men with early-stage, low- to intermediate-risk prostate cancer who are being watched rather than treated right away.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07574541

• TSLPR-CART therapy for CRLF2-R/TSLPR–expressing B-ALL in adults

  This study tests a CAR T-cell treatment called TSLPR-CART in adults whose B-ALL cells overexpress TSLPR and have not responded to standard therapy.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07572136

• Topical curcumin (VAS-101) for sickle cell disease: escalating doses tested

  We are testing whether a skin gel containing curcumin can be safely used in adults with stable sickle cell disease to improve how red blood cells function.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07566494

• Role of theta brain waves in how kids control thoughts and actions

  This study tests whether theta-frequency brain activity can reveal how children with ADHD or OCD, and healthy kids, manage thinking and behavior during tasks.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07566468

• Tirzepatide and Brain Dopamine in Alcohol Use Disorder

  This study tests whether tirzepatide can alter brain dopamine responses and cue reactivity in people with alcohol use disorder and in healthy controls.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07559500

• PTH-IA treatment for Jansen's Metaphyseal Chondrodysplasia

  This study will test whether twice-daily subcutaneous injections of PTH-IA are safe and can reduce abnormal PTH signaling in children and adults with Jansen's Metaphyseal Chondrodysplasia.

  Recruiting Phase 1/2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07541209

• Multimodal prospective approach to understand acute and chronic lung transplant rejection

  This project will see if blood tests, airway sampling, imaging, and genetic analyses can identify which adults who have had or are being evaluated for a lung transplant will develop antibody‑mediated rejection and later chronic graft dysfunction.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07516379

• Intravenous brincidofovir treatment for progressive multifocal leukoencephalopathy

  This trial will test whether intravenous brincidofovir given twice weekly for up to 12 weeks can help adults with progressive multifocal leukoencephalopathy (PML).

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07511049

• Autologous B7-H3 CAR T Cells in Advanced Small Cell Lung Cancer and Extrapulmonary Neuroendocrine Cancer

  This study tests a patient’s own B7-H3 CAR T cells to see if they can help people 18 and older whose small cell lung cancer or EPNEC has come back or hasn’t responded to prior treatment.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07509034

• Genetic factors in Turner syndrome

  This project will collect whole-genome samples from people with Turner syndrome and their family members to try to find genes linked to fertility and other health problems.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07502586

• NCI CCDI registry for very rare pediatric and young adult solid tumors

  This registry collects medical records and tumor genetic data from children, teens, and young adults (1 month–39 years) newly diagnosed with very rare solid tumors to help researchers learn more and guide future treatments.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07489378

• 18F‑Fluorocholine PET/MRI and NeuroEXPLORER PET/CT to locate parathyroid tumors

  This trial will test whether 18F‑Fluorocholine PET/MRI and NeuroEXPLORER PET/CT scans can better find overactive or cancerous parathyroid glands in adults scheduled for surgery.

  Recruiting Phase 2/3 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07444723

• Immune profiling during first-line pirtobrutinib treatment for CLL/SLL

  This will test pirtobrutinib as a first treatment for adults with CLL or SLL and see how it changes immune cells in the blood and lymph nodes.

  Recruiting Early Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07428707

• Thymus removal and immune aging in people with Down syndrome

  This study will try to see if removing part of the thymus affects immune health over time in people aged 1 and older with Down syndrome, comparing those who had thymectomy to those who did not and to unaffected household relatives.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07416201

• LMP744 (an indenoisoquinolone) for people with recurrent glioblastoma

  This trial will test whether the drug LMP744 can shrink tumors or slow progression in adults whose glioblastoma has returned after prior treatment.

  Recruiting Phase 1/2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07416188

• Azacitidine and abatacept for relapsed or refractory T-cell lymphoma

  This study tests a combination of azacitidine and abatacept to see if it can shrink tumors in adults whose T-cell lymphoma has come back or not responded to treatment.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07388563

• Identifying genetic variants in non-obstructive azoospermia and primary ovarian insufficiency

  This project will collect DNA from adults with NOA, oligospermia, or POI to try to find gene changes that may cause their infertility.

  Recruiting at 2 sites National Institutes of Health Clinical Center (CC) · Bethesda, Maryland and 1 other locations · NCT07357701

• Using CD22 CAR T-cells to extend remission after commercial CD19 CAR T-cell therapy in children, adolescents, and adults with relapsed/refractory B‑ALL

  This will try giving CD22-targeted CAR T-cells to people aged 3–65 who are in remission after CD19 CAR T-cell therapy to see if it helps keep their B-ALL from coming back longer.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07328503

• CYT107 (recombinant interleukin-7) to treat Kaposi sarcoma in adults with HIV and poor T‑cell recovery

  This trial tests whether CYT107, a laboratory-made interleukin-7, can shrink Kaposi sarcoma tumors in adults with HIV who have poor T‑cell recovery.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07308886

• Tofacitinib safety for people with primary Sjogren disease

  This study will test whether the oral pill tofacitinib is safe and tolerable for adults with primary Sjogren disease and mild-to-moderate symptoms.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07281456

• Effects of everyday allergen and skin, airway, and gut exposures on inflammation and barrier health

  This study will test whether everyday exposures from common skin and hair products, processed foods, and air change inflammation and barrier health in healthy adults aged 18 to 80.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07271381

• Baricitinib for people with STAT3‑related Hyper‑IgE (Job) syndrome who have lupus-like disease or atopic dermatitis

  This trial will test whether the JAK inhibitor baricitinib can be taken safely and may reduce lupus-like symptoms or severe eczema in people aged 12 and older with STAT3-related Hyper‑IgE (Job) syndrome.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07262983

• Using a tiny high-resolution camera and mouth-cell testing to find oral precancer

  This project tests whether a high-resolution microendoscope or liquid-based cytology can better find precancer and guide biopsy decisions in people aged 30–80 with visible oral lesions.

  Recruiting National Institutes of Health Clinical Center (CC) · Taipei, Taipei · NCT07260344

• BPL-1357 influenza vaccine by nasal spray or injection for H1N1 exposure

  Test whether two doses of the BPL-1357 flu vaccine, given by nasal spray or by injection, protect healthy adults 18–55 from H1N1 after controlled exposure.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland and 1 other locations · NCT07215858

• Acamprosate for ALS with C9orf72 mutation

  This study tests whether acamprosate can be safely used to see if it helps people with ALS who carry a C9orf72 mutation.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07204977

• Randomized stepped-wedge testing emapalumab for APECED enteritis

  This trial will test whether emapalumab can lessen gastrointestinal symptoms in people with APECED-related enteritis.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07202598

• Hepatic Lipid Metabolism in Alcohol Use Disorder

  This study tests how alcohol use disorder affects liver lipid metabolism by comparing liver biopsy transcriptomes during early and later withdrawal in adults undergoing inpatient detoxification.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07191561

• PET scan to image PDE4B in people with Alzheimer’s disease or mild cognitive impairment

  We will test whether a new PET tracer can measure PDE4B levels in the brains of people aged 50 and older with Alzheimer's or mild cognitive impairment compared with healthy volunteers.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07169630

• Combining donor-derived anti-CD19 CAR-T cells with haploidentical transplant using post-transplant cyclophosphamide

  This trial tests whether giving donor-derived anti-CD19 CAR-T cells together with a haploidentical bone marrow transplant using post-transplant cyclophosphamide can help adults (18–75) with high‑risk CD19+ blood cancers.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07162038

• Understanding how brain changes relate to smell disorders over time

  This small, year-long study tests how brain activity and smell-related inflammation relate to different smell disorders in adults.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07149428

• Brain and reflex testing to distinguish organic and functional tics

  This test uses EEG, EMG, blink reflex, and pre-pulse inhibition recordings to see if brain and reflex signals can tell apart adults with organic tics, adults with functional tics, and people without tics.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07137442

• Longitudinal multi-omic platelet volunteer program

  This program will collect regular blood samples and health data from healthy adults to test how platelets, genes, and proteins change over time.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07137429

• Quadrivalent influenza HA stem vaccine (SteMos1) with or without ALFQ adjuvant in healthy adults

  This will test a new quadrivalent 'stem' flu vaccine called SteMos1 given with or without the ALFQ adjuvant in healthy adults aged 18–50 who have had at least one flu vaccine since 2020.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07111078

• Fatty acid (fish oil) supplements for dermatomyositis

  This trial will test whether omega‑3 (fish oil) supplements combined with a general healthy diet can help adults with mild to moderately active dermatomyositis or juvenile dermatomyositis.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07111065

• Tracking amyloid in the aging brain with PET scans

  PET scans will be used to track amyloid in people aged 55 and older enrolled in the Baltimore Longitudinal Study of Aging to see if amyloid changes are linked to memory decline or other brain changes.

  Recruiting National Institutes of Health Clinical Center (CC) · Baltimore, Maryland · NCT07099053

• ENLIGHT algorithm to find treatment options for advanced metastatic breast cancer

  This test uses the ENLIGHT algorithm to try to find approved drugs that might work better for adults with triple-negative or endocrine therapy–resistant metastatic breast cancer.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07067138

• Tirzepatide for people with metabolic alcohol-associated liver disease and alcohol use disorder

  This trial will test whether the weight-loss drug tirzepatide can help adults with alcohol use disorder and metabolic alcohol-associated liver disease reduce drinking, lose weight, and lower liver fat.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07046819

• Alcohol's immediate effects on brain PDE4B imaging

  This will see if a controlled intravenous dose of alcohol increases PET tracer binding to PDE4B in healthy adults who drink socially.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07027839

• Esophageal string test to screen for eosinophilic esophagitis in adults of African descent with swallowing problems

  This study will test whether a 1-hour esophageal string test can detect eosinophilic esophagitis in adults born in Africa (or with African parents) who have trouble swallowing.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland and 2 other locations · NCT07027826

• Individuals and families with DDX41 or similar inherited blood cancer risk variants

  We will follow people and their family members who have DDX41 or other inherited blood cancer risk variants to see how often and when they develop MDS or AML and related health changes.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07019155

• Making lower-limb exoskeletons usable for children and young adults

  This project will test whether a wearable leg exoskeleton, sometimes paired with electrical muscle stimulation, can help children and young adults with cerebral palsy, muscular dystrophy, spina bifida, or incomplete spinal cord injury walk and move during everyday tasks.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06998134

• rhIL-15 with dinutuximab plus irinotecan and temozolomide for relapsed or refractory neuroblastoma in children and young adults

  This trial will test whether adding rhIL-15 to dinutuximab with irinotecan and temozolomide helps children and young adults (ages 3-35) whose neuroblastoma has returned or not responded to prior treatments.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06995872

• Using PET/CT Imaging to Detect Amyloidosis in Patients Treated with Anakinra

  This study is testing a new imaging method to see if it can help find amyloidosis in adults with cryopyrin-associated periodic syndromes who have been treated with anakinra.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06974877

• Base editing of blood stem cells and T cells to treat CD40L‑HyperIgM syndrome (single patient)

  This treatment will try to repair the CD40L gene in a man's own blood stem cells and T cells using base editing to restore immune function in CD40L‑HyperIgM syndrome.

  Recruiting Phase 1/2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06959771

• Understanding genetic factors in autoimmune diseases in Peru

  This study is looking to see how genetic differences affect autoimmune diseases in people from Peru to better understand their health needs.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland and 1 other locations · NCT06948110

• Fostamatinib to see if it’s safe for lung transplant patients with donor-specific antibodies

  This trial tests whether taking fostamatinib is safe for adults who have donor-specific antibodies after a lung transplant.

  Recruiting at 4 sites Phase 1 National Institutes of Health Clinical Center (CC) · Stanford, California and 3 other locations · NCT06948097

• Understanding genetic risks of immune responses after blood transfusions in sickle cell disease

  This study is trying to find out how genetics affect the immune response to blood transfusions in people with sickle cell disease to help improve their treatment.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06944067

• Using baricitinib to treat Kohlmeier-Degos disease with neurological symptoms

  This study is testing if the medication baricitinib can help adults with Kohlmeier-Degos disease who have neurological symptoms feel better over 24 weeks.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06923072

• Imaging brain inflammation in people with long COVID symptoms

  This study is testing if a brain scan can show signs of inflammation in people aged 18 to 70 who have neurological symptoms after COVID-19, and whether a treatment called IVIg can help them feel better.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06920628

• Understanding brain changes during puberty in children

  This study looks at how the brains of healthy kids aged 9 to 14 change during puberty to better understand their development.

  Recruiting National Institutes of Health Clinical Center (CC) · Baltimore, Maryland · NCT06912724

• Vaccination against Epstein-Barr Virus in Healthy Adults

  This study is testing two new vaccines for the Epstein-Barr Virus in healthy adults aged 18 to 29 to see if they can safely boost the immune response against the virus.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06908096

• Personalized T cells engineered to target TP53 or RAS mutations in blood cancers

  This trial will try using a patient's own T cells, modified to recognize specific TP53 or RAS mutations, to treat adults with certain blood cancers.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06904066

• Anti-mesothelin TNhYP218 CAR T cell therapy for mesothelin-expressing solid tumors

  This treatment will test whether a person's own engineered CAR T cells that target mesothelin can help adults with mesothelin-expressing solid tumors, including mesothelioma, that have returned or spread after standard therapy.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06885697

• Assessing appearance concerns in Neurofibromatosis Type 1 patients

  This study is trying to understand how appearance-related concerns affect people with Neurofibromatosis Type 1 by gathering their thoughts and experiences through questionnaires and discussions.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06880991

• Imaging PDE4D in the brain and body using a new radiotracer

  This study is testing a new imaging tool to see how well it can track a specific protein in the brains and bodies of healthy adults to help us understand its role in brain disorders.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06874205

• FGFR4-directed CAR T cell therapy for children and young adults with recurrent or refractory rhabdomyosarcoma

  This trial will try a personalized CAR T cell treatment that targets the FGFR4 protein for people aged 3–39 whose rhabdomyosarcoma has returned or not responded after at least two prior treatments.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06865664

• Testing a new flu vaccine with and without an adjuvant in healthy adults

  This study is testing a new flu vaccine with and without an added booster to see if it helps healthy adults aged 18 to 50 build a stronger immune response.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06863142

• Effects of environment on drinking behaviors in people with alcohol use disorder

  This study is testing how different activities and surroundings can help people with alcohol use disorder drink less and feel better.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Baltimore, Maryland · NCT06860607

• Best germline DNA source to guide drug dosing after allogeneic stem cell transplant

  This project will test whether blood, skin, or other tissue samples give the most reliable genetic information to guide medicine dosing for adults who receive an allogeneic stem cell transplant.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06856226

• Hormone replacement for adolescents with premature ovarian insufficiency

  This study will test estrogen patches plus progesterone in girls and young women aged 11–19 with premature ovarian insufficiency to see if hormone replacement improves bone density, metabolic markers, muscle strength, and cardiovascular health.

  Recruiting Phase 3 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06851754

• Investigating how a specific gene affects alcohol consumption and brain activity

  This study is testing how a specific gene might influence drinking habits and brain activity in healthy adults aged 21 to 60.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06819189

• Adding lenacapavir to ART to try to shrink hidden HIV reservoirs

  This study will test whether giving lenacapavir in addition to a stable ART regimen can reduce hidden HIV reservoirs in adults who have had undetectable viral loads for at least three years.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06819176

• Imaging brain protein levels in people with alcohol use disorder

  This study is testing if the levels of a brain protein called PDE4B change in people with alcohol use disorder during withdrawal and after they stop drinking for a while.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06795581

• Study of childhood high blood pressure and its genetic factors

  This study is trying to find out how genes affect high blood pressure in kids by looking at their health over several years to help create better treatments.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06778239

• Understanding the genetic causes of cartilage tumors and vascular anomalies

  This study is trying to find out the genetic reasons behind rare conditions like Ollier disease and Maffucci syndrome that cause cartilage tumors and blood vessel issues in people aged 2 and older.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06749366

• Biorepository for people with allergic diseases

  This study is collecting samples and information from people with allergies or sinus issues to help researchers learn more about these conditions and improve future treatments.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06732414

• Using soquelitinib to treat autoimmune lymphoproliferative syndrome

  This study is testing if a new drug called soquelitinib can help people with autoimmune lymphoproliferative syndrome feel better and manage their symptoms.

  Recruiting at 3 sites Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland and 2 other locations · NCT06730126

• Understanding heart disease in young people with type 2 diabetes

  This study looks at what causes heart disease in young people aged 12 to 25 with type 2 diabetes, those who are overweight, and healthy peers to see how their heart health compares over time.

  Recruiting at 2 sites National Institutes of Health Clinical Center (CC) · Washington D.C., District of Columbia and 1 other locations · NCT06730113

• Predicting motor skill errors before they happen

  This study is testing if we can predict mistakes in movement up to one second before they happen in healthy young adults to help prevent those errors.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06707207

• Exploring the effects of heavy alcohol use on oral health and saliva

  This study is trying to see how heavy drinking affects oral health and inflammation in people with alcohol use disorder compared to those without it.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06684483

• Monitoring substance use and tracking relapse through smartphone data

  This study is testing a smartphone app to see how tracking people's phone use and habits can help understand and prevent drug and alcohol relapse in adults.

  Recruiting National Institutes of Health Clinical Center (CC) · Baltimore, Maryland · NCT06676059

• Understanding rare lipid disorders and their effects over time

  This study is trying to understand how rare lipid disorders change over time and how they respond to treatments in people aged 10 and older.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06676046

• Testing ManNAc for treating kidney disease FSGS

  This study is testing if a new oral treatment called ManNAc can help adults with kidney disease FSGS by reducing protein levels in their urine and checking how safe it is over 12 weeks.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06664814

• Improving the Desmopressin test for diagnosing Cushing Syndrome

  This study is testing a new way to use the Desmopressin test to better diagnose different types of Cushing syndrome in adults who might have the condition.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06635629

• Observing how congenital myasthenic syndromes affect patients over time

  This study is tracking how congenital myasthenic syndromes affect people over five years to better understand the condition and help improve future treatments.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06630650

• Understanding how social factors affect cognitive function after stroke

  This study looks at how social factors, like support from family and friends, affect how well people recover mentally after having a stroke.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06615973

• Assessing the safety and infectivity of a malaria challenge agent in healthy adults

  This study is testing how the malaria parasite affects healthy adults and how their immune systems respond, to help develop better vaccines.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06607003

• Gaze-Contingent Music Therapy to Help Kids with Anxiety

  This study is testing if adding a special music therapy to regular talk therapy can help kids and teens with anxiety feel better.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06595953

• Genetic analysis of rare diseases in non-US populations

  This study is trying to find the genetic causes of rare diseases in children and their families living outside the U.S. to improve understanding and access to testing in those areas.

  Recruiting National Institutes of Health Clinical Center (CC) · Moka · NCT06595940

• Evaluating remnants of SARS-CoV-2 in people recovering from COVID-19

  This study is trying to see if people who have recovered from COVID-19 still have leftover pieces of the virus in their bodies, especially those with ongoing neurological symptoms.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06577467

• Using brain stimulation to improve learning and decision-making

  This study is testing if a type of brain stimulation can help healthy adults learn better and make smarter decisions.

  Recruiting Early Phase 1 National Institutes of Health Clinical Center (CC) · Baltimore, Maryland · NCT06561828

• Understanding blood vessel diseases and inflammation

  This study is trying to understand how blood vessel diseases and inflammation are connected by looking at people with these conditions, their healthy family members, and other healthy volunteers.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06552767

• Motion Reset for preventing cybersickness during virtual reality

  This project will test if Motion Reset software can reduce cybersickness in healthy adults using virtual reality.

  Recruiting at 2 sites National Institutes of Health Clinical Center (CC) · Ames, Iowa and 1 other locations · NCT06552754

• Screening and evaluation for substance use disorders at NIDA

  This study is trying to see if people with and without substance use disorders can join future research at NIDA to help understand drug use and improve treatments.

  Recruiting National Institutes of Health Clinical Center (CC) · Baltimore, Maryland · NCT06552741

• Testing a new drug for treatment-resistant depression

  This study is testing a new drug called HNK to see if it can help people with treatment-resistant depression feel better when other medications haven't worked.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06511908

• Pupillometry to measure pain and sensory problems in people with NF1

  This study will test whether the AlgometRx Nociometer, a pupillometry device, can measure pain and other sensory problems in children and adults with NF1.

  Recruiting at 2 sites National Institutes of Health Clinical Center (CC) · Washington D.C., District of Columbia and 1 other locations · NCT06507748

• Using a new imaging agent to detect various cancers

  This study is testing a new imaging agent to see if it can better detect certain cancers in adults compared to standard imaging methods.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06503146

• Exploring movement in children and young adults with cerebral palsy

  This study is testing new technologies to see how children and young adults with cerebral palsy move, both with and without a robotic exoskeleton, to help improve their mobility.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06498596

• Expansion of a genetic and data repository for rare eye diseases

  This study is collecting genetic and health information from people with rare eye diseases like Aniridia and Best disease, along with their family members, to help improve understanding and treatment options for these conditions.

  Recruiting at 2 sites National Institutes of Health Clinical Center (CC) · Bethesda, Maryland and 1 other locations · NCT06491615

• Preoperative targeted radiation before surgery for recurrent abdominal adrenocortical carcinoma

  This study tests giving a short course of focused external beam radiation before surgery in adults whose adrenocortical cancer has come back and appears removable.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06487481

• Understanding how the brain reacts to frustration in healthy adults

  This study is trying to see how the brains of healthy adults react to frustration by using special tasks and brain imaging techniques.

  Recruiting Early Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland and 1 other locations · NCT06484088

• Using Suvorexant to understand brain mechanisms in alcohol use disorder

  This study is testing whether the sleep medication Suvorexant can help people with alcohol use disorder by looking at its effects on their brain and cravings for alcohol.

  Recruiting Phase 1/2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06484075

• Understanding how Staphylococcus aureus interacts with human cells using tonsil tissues

  This study is testing how Staphylococcus aureus affects human cells using tonsil tissues from people having their tonsils removed to learn more about immune responses.

  Recruiting at 2 sites National Institutes of Health Clinical Center (CC) · Bethesda, Maryland and 1 other locations · NCT06479837

• Targeted alpha therapy [212Pb]VMT-Alpha-NET for SSTR-positive metastatic or inoperable GI neuroendocrine, pheochromocytoma/paraganglioma, small cell lung, kidney, and head & neck cancers

  This trial will try an experimental targeted alpha-particle drug called [212Pb]VMT-Alpha-NET in adults whose metastatic or inoperable tumors show somatostatin receptor (SSTR) expression.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06479811

• Using dupilumab to help patients with hypereosinophilic syndrome who still have symptoms

  This study is testing if adding dupilumab to the treatment of adults with hypereosinophilic syndrome can help reduce their ongoing symptoms.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06477653

• Understanding how the brain processes unpleasant sensations of pain and effort

  This study is testing how the brains of people with chronic fatigue syndrome and healthy volunteers respond to pain and physical effort to better understand their experiences.

  Recruiting Early Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06472622

• Understanding the impact of mood disorders and treatment responses

  This study is trying to learn more about how people with depression and bipolar disorder respond to treatment by talking to them weekly for up to 12 weeks to improve future care and predict how well medications might work.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06462196

• Targeted treatment for advanced gastrointestinal neuroendocrine tumors and pheochromocytoma

  This study is testing a new drug to see if it can help people with advanced gastrointestinal neuroendocrine tumors and pheochromocytoma who have already tried other treatments.

  Recruiting Phase 1/2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06427798

• Genetic testing to personalize belinostat treatment for high-grade neuroendocrine carcinomas

  This study is testing if genetic testing can help find the right dose of the cancer drug belinostat for people with high-grade neuroendocrine carcinomas to improve treatment results and reduce side effects.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06406465

• Understanding the natural history of Kaposi Sarcoma

  This study looks at how Kaposi Sarcoma affects people with weakened immune systems, like those with HIV, by tracking their symptoms and health over time.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06375122

• Treatment for Chronic Lymphocytic Leukemia using modified T cells

  This study is testing a new treatment using modified T cells to see if it can help people with chronic lymphocytic leukemia that hasn't responded to other therapies.

  Recruiting Phase 1/2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06364423

• Re-irradiation for recurrent glioblastoma

  This study is testing a new way to safely give radiation treatment again to adults with recurring glioblastoma to see if it can improve their options after their tumors come back.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06344130

• Evaluation of secondary hemophagocytic lymphohistiocytosis and its immune mechanisms

  This study is trying to understand the immune system's role in secondary hemophagocytic lymphohistiocytosis by looking closely at patients' health and blood over a year to find better treatment options.

  Recruiting at 2 sites National Institutes of Health Clinical Center (CC) · Bethesda, Maryland and 1 other locations · NCT06339177

• Does starting with a low-carb versus a low-fat diet change how much body fat you lose?

  This will try whether starting with a low-carb or a low-fat diet changes body fat loss in adults with overweight or obesity over two back-to-back four-week diets.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06325722

• Base editing of blood stem cells to fix the CYBB mutation in X-linked chronic granulomatous disease.

  This trial will try base-editing a person's own blood stem cells to fix a specific CYBB mutation in adult men with X-linked chronic granulomatous disease.

  Recruiting Phase 1/2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06325709

• Testing hymecromone in adults with interstitial lung disease

  This study is testing a new medication called hymecromone to see if it can help adults with progressive interstitial lung disease feel better and improve their lung function.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Research Triangle Park, North Carolina · NCT06325696

• Understanding red blood cell lifespan in sickle cell disease and hemoglobin disorders

  This study is trying to see how long red blood cells last in people with sickle cell disease and other blood disorders to help improve their treatment.

  Recruiting Early Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06313398

• Pacritinib for adults and adolescents (12+) with myelodysplastic syndromes or MDS/MPN

  This study will try the oral medicine pacritinib in people aged 12 and older with MDS or MDS/MPN to see if it helps their disease.

  Recruiting Phase 1/2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06303193

• Collection of biological samples for research on head and neck disorders

  This study is collecting biological samples from people with head and neck disorders to see how these conditions develop and find better ways to diagnose and treat them.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06303180

• Understanding RYR1-related muscle disorders

  This study is looking to learn more about RYR1-related muscle disorders by tracking the health and progress of participants aged 7 and older over several years.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06287762

• Observing how the environment affects reproductive health

  This study looks at how different environmental factors might affect reproductive health in people aged 8 and older, including issues like infertility and hormone problems.

  Recruiting National Institutes of Health Clinical Center (CC) · Research Triangle Park, North Carolina · NCT06280807

• Urolithin A supplementation's effects on glucose metabolism in older adults

  This study is testing if a natural supplement called Urolithin A can help older adults improve their blood sugar control and insulin response.

  Recruiting National Institutes of Health Clinical Center (CC) · Baltimore, Maryland · NCT06274749

• Measuring how proteins are replaced in healthy adults over time

  This study is testing how quickly proteins are replaced in healthy adults of different ages to see how aging affects this process.

  Recruiting National Institutes of Health Clinical Center (CC) · Baltimore, Maryland · NCT06269653

• Understanding how acamprosate affects brain function in alcohol use disorder

  This study is testing whether acamprosate can improve brain function and reduce anxiety and cravings in people with alcohol use disorder.

  Recruiting Phase 4 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06269627

• Combination of a HER2-targeting vaccine and immunotherapy for advanced endometrial cancer

  This study is testing a new combination treatment for advanced endometrial cancer that includes a personalized vaccine made from patients' own blood, along with other medications, to see if it helps those whose cancer has progressed after other treatments.

  Recruiting Phase 1/2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06253494

• Evaluating adrenal gland function using a new imaging agent in patients with hormone-related conditions

  This study is testing a new imaging agent to see if it can help find adrenal tumors in adults with hormone-related conditions like hyperaldosteronism or hypercortisolism.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06246357

• Combining Lurbinectedin and Avelumab for Small Cell Carcinoma of the Bladder

  This study is testing if a combination of two drugs, lurbinectedin and avelumab, can help people with small cell carcinoma of the bladder and similar tumors feel better when their cancer has come back or spread.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06228066

• Neoadjuvant chemotherapy with a vaccine for HPV-related throat cancer

  This study is testing if a new vaccine combined with standard chemotherapy can help people with HPV-related throat cancer live longer and avoid radiation treatment.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06223568

• Comparing fixed and adjusted meal tests for blood glucose response

  This study is testing whether giving people fixed or adjusted meal sizes affects their blood sugar levels differently during a mixed meal tolerance test.

  Recruiting National Institutes of Health Clinical Center (CC) · Phoenix, Arizona · NCT06223555

• Monitoring for cancer risk in neurofibromatosis type 1 tumors

  This study is trying to find out which harmless tumors in people with neurofibromatosis type 1 might turn into cancer so that doctors can better monitor patients at risk.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06222203

• Using ultra-low field MRI to assess brain conditions

  This study is testing a new type of MRI that uses lower magnetic fields to see if it can better detect brain problems in people of all ages, including those with neurological symptoms.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06203626

• Using enasidenib to treat IDH2-mutated sinonasal and skull base tumors

  This study is testing if a new drug called enasidenib can help people with rare nasal or skull base cancers that have a specific mutation and haven't responded to other treatments.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06176989

• Understanding how immune diseases affect the nervous system

  This study looks at how immune diseases affect the nervous system in patients and their healthy relatives to better understand the connection between these two systems.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06169150

• Pembrolizumab plus N-803, with or without PD-L1 t‑haNK cells, for operable HPV‑negative head and neck cancer

  This trial will test whether giving N‑803 with pembrolizumab, and in some patients adding PD‑L1 t‑haNK immune cells before surgery, can improve outcomes for people with HPV‑negative resectable head and neck squamous cell carcinoma.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06161545

• Combining two drugs to treat rare genitourinary tumors

  This study is testing whether a combination of two drugs can help adults with rare and aggressive genitourinary tumors feel better and improve their treatment options.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06161532

• Testing PLX038 for brain and spinal cord tumors with MYC or MYCN amplifications

  This study is testing a new treatment called PLX038 for adults with brain and spinal cord tumors that have specific gene changes to see if it helps improve their condition.

  Recruiting Phase 1/2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06161519

Showing recruiting studies first, then the newest. Describe your situation to find the ones that fit you.

Quick answers

How many clinical trials run by National Institutes of Health Clinical Center (CC) are recruiting right now?

630, as of November 12, 2026. 2 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 22 countries. The most sites are in United States (623 trials), Mali (4 trials), Italy (2 trials), Turkey (Türkiye) (2 trials), Canada (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 79, Phase 1: 66, Phase 1/2: 47, Early Phase 1: 5. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →